The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $6.60 in the prior trading day, GoodRx Holdings Inc (NASDAQ: GDRX) closed at $6.70, up 1.52%. In other words, the price has increased by $1.52 from its previous closing price. On the day, 1.01 million shares were traded. GDRX stock price reached its highest trading level at $6.86 during the session, while it also had its lowest trading level at $6.565.
Ratios:
Our goal is to gain a better understanding of GDRX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.06. For the most recent quarter (mrq), Quick Ratio is recorded 6.29 and its Current Ratio is at 6.29. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.11.
On March 25, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $7.50 to $10.
JP Morgan Upgraded its Neutral to Overweight on March 01, 2024, whereas the target price for the stock was revised from $7 to $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 30 ’23 when Wagner Scott bought 21,652 shares for $5.76 per share. The transaction valued at 124,806 led to the insider holds 182,900 shares of the business.
Wagner Scott bought 26,348 shares of GDRX for $155,482 on Nov 29 ’23. The insider now owns 161,248 shares after completing the transaction at $5.90 per share. On Nov 28 ’23, another insider, Wagner Scott, who serves as the insider of the company, bought 4,157 shares for $6.00 each. As a result, the insider paid 24,940 and bolstered with 134,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GDRX now has a Market Capitalization of 2513873408 and an Enterprise Value of 3044704000. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.29 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 4.058 whereas that against EBITDA is 45.449.
Stock Price History:
The Beta on a monthly basis for GDRX is 1.36, which has changed by 0.321499 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, GDRX has reached a high of $9.37, while it has fallen to a 52-week low of $4.14. The 50-Day Moving Average of the stock is -4.64%, while the 200-Day Moving Average is calculated to be 5.02%.
Shares Statistics:
The stock has traded on average 1.42M shares per day over the past 3-months and 1613300 shares per day over the last 10 days, according to various share statistics. A total of 92.36M shares are outstanding, with a floating share count of 77.39M. Insiders hold about 79.36% of the company’s shares, while institutions hold 14.44% stake in the company. Shares short for GDRX as of 1713139200 were 8800356 with a Short Ratio of 5.99, compared to 1710460800 on 9852345. Therefore, it implies a Short% of Shares Outstanding of 8800356 and a Short% of Float of 10.569999.
Earnings Estimates
A comprehensive evaluation of GoodRx Holdings Inc (GDRX) is underway, with the input of 15.0 analysts contributing to its current rating.On average, analysts expect EPS of $0.09 for the current quarter, with a high estimate of $0.11 and a low estimate of $0.08, while EPS last year was $0.07. The consensus estimate for the next quarter is $0.09, with high estimates of $0.12 and low estimates of $0.08.
Analysts are recommending an EPS of between $0.46 and $0.32 for the fiscal current year, implying an average EPS of $0.37. EPS for the following year is $0.45, with 16.0 analysts recommending between $0.57 and $0.36.
Revenue Estimates
16 analysts predict $199.96M in revenue for the current quarter. It ranges from a high estimate of $202.4M to a low estimate of $197M. As of the current estimate, GoodRx Holdings Inc’s year-ago sales were $189.68MFor the next quarter, 16 analysts are estimating revenue of $201.19M. There is a high estimate of $205.34M for the next quarter, whereas the lowest estimate is $198M.
A total of 19 analysts have provided revenue estimates for GDRX’s current fiscal year. The highest revenue estimate was $812.72M, while the lowest revenue estimate was $800M, resulting in an average revenue estimate of $803.96M. In the same quarter a year ago, actual revenue was $750.26MBased on 19 analysts’ estimates, the company’s revenue will be $864.95M in the next fiscal year. The high estimate is $929.8M and the low estimate is $839.8M.
